Sanofi ADR Dividends
The next dividend date for Sanofi ADR has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Sanofi ADR (SNY)
| 05/04/2026 | 04/14/2026 | 05/04/2026 | 06/03/2026 | $2.42 |
| 05/09/2025 | 04/15/2025 | 05/09/2025 | 06/12/2025 | $2.21 |
| 05/09/2024 | 03/26/2024 | 05/10/2024 | 06/06/2024 | $2.04 |
| 05/30/2023 | 02/15/2023 | 05/31/2023 | 06/23/2023 | $1.90 |
| 05/26/2022 | --- | 05/27/2022 | 06/27/2022 | $0.30 |
| 05/04/2022 | 04/20/2022 | 05/05/2022 | 05/31/2022 | $1.75 |
| 05/03/2021 | 03/23/2021 | 05/04/2021 | 05/26/2021 | $1.91 |
| 04/30/2020 | 03/05/2020 | 05/01/2020 | 05/26/2020 | $1.75 |
| 05/07/2019 | 02/25/2019 | 05/08/2019 | 05/31/2019 | $1.74 |
| 05/09/2018 | 02/12/2018 | 05/10/2018 | 06/04/2018 | $1.86 |
More About Sanofi ADR
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Owning Sanofi ADR Stock on the Dividend Date
If you own Sanofi ADR stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Sanofi ADR stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Sanofi ADR stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Sanofi ADR stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Sanofi ADR dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Sanofi ADR Dividends
You can contact us any time if you would like to ask questions about Sanofi ADR dividends or anything else related to the stock market.